RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significant intra-...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227884063883264 |
|---|---|
| author | I. V. Szirov E. V. Malichenko |
| author_facet | I. V. Szirov E. V. Malichenko |
| author_sort | I. V. Szirov |
| collection | DOAJ |
| description | Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significant intra-group differences. Ramipril is the one of the most studied drug of this group recommended for patients after acute myocardial infarction. |
| format | Article |
| id | doaj-art-9eb43592c15445ffbe2584257d33fed8 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-9eb43592c15445ffbe2584257d33fed82025-08-23T10:00:20ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-0134586010.20996/1819-6446-2007-3-4-58-60510RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTIONI. V. Szirov0E. V. Malichenko1Moscow State Medial Stomatological UniversityMoscow State Medial Stomatological UniversityAngiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significant intra-group differences. Ramipril is the one of the most studied drug of this group recommended for patients after acute myocardial infarction.https://www.rpcardio.online/jour/article/view/510acute myocardial infarctionangiotensin converting enzymeramipril |
| spellingShingle | I. V. Szirov E. V. Malichenko RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION Рациональная фармакотерапия в кардиологии acute myocardial infarction angiotensin converting enzyme ramipril |
| title | RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION |
| title_full | RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION |
| title_fullStr | RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION |
| title_full_unstemmed | RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION |
| title_short | RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION |
| title_sort | ramipril in therapy of patients after myocardial infarction |
| topic | acute myocardial infarction angiotensin converting enzyme ramipril |
| url | https://www.rpcardio.online/jour/article/view/510 |
| work_keys_str_mv | AT ivszirov ramiprilintherapyofpatientsaftermyocardialinfarction AT evmalichenko ramiprilintherapyofpatientsaftermyocardialinfarction |